ASH 2021 Conference Coverage on VuMedi

 

ASH 2021 Conference Coverage on VuMedi
E

ASH 2021 NGS Evaluation of the EQoL-MDS Trial: Preliminary Analysis of Eltrombopag for Thrombocytopenia of LR-MDS

By ASH 2021 Conference Coverage on VuMedi FEATURING Esther Oliva
By ASH 2021 Conference Coverage on VuMedi FEATURING Esther Oliva
121 views
December 23, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

09:50
Incyte

Managing Chronic GVHD Master Class Series: Best Practices at 100 Day…

Feat. C. Cutler

Featured Video

14:18
Incyte

Early Intervention in Chronic GVHD: Evaluating Efficacy and Safety O…

Feat. H. Ali
MDS and MPN
06:20

Retrospective Head-to-Head Comparison Between Pacritinib and Ruxolit…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

117 views
07:13

FDA Approval and Safety Analysis of Pacritinib in Patients With Myel…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

166 views
10:26

ASH 2021 Updates on a Pooled Analysis of the COMFORT-I & II Studies:…

ASH 2021 Conference Coverage on VuMedi

S. Verstovsek

317 views
06:04

ASH 2021 Clinical and Pathological Characteristics of Hypocellular M…

ASH 2021 Conference Coverage on VuMedi

K. Kim

155 views
05:14

ASH 2021 NGS Evaluation of the EQoL-MDS Trial: Preliminary Analysis …

ASH 2021 Conference Coverage on VuMedi

E. Oliva

121 views
11:04

ASH 2021: Evaluation of IWG 2006 Response Criteria in Patients with …

ASH 2021 Conference Coverage on VuMedi

J. Bewersdorf

128 views
06:52

ASH 2021: A Phase 3 Study of Hepcidin Mimetic Rusfertide in Patients…

ASH 2021 Conference Coverage on VuMedi

S. Verstovsek

100 views
11:17

ASH 2021 Updates on the Management of Polycythemia Vera

ASH 2021 Conference Coverage on VuMedi

A. Kuykendall

41 views
04:45

ASH 2021 on LR-MDS: Factors Predicting Progression to HR-MDS and AML…

ASH 2021 Conference Coverage on VuMedi

A. Jain

101 views
08:59

ASH 2021 Update on the Outcomes of Therapy-Related Myeloid Neoplasms…

ASH 2021 Conference Coverage on VuMedi

M. Shah

17 views
08:12

ASH 2021 Efficacy and Safety of Parsaclisib+Ruxolitinib Combination …

ASH 2021 Conference Coverage on VuMedi

A. Yacoub

17 views
08:30

ASH 2021 Presentation on Tagraxofusp, a First-in-Class CD123-Targete…

ASH 2021 Conference Coverage on VuMedi

A. Yacoub

75 views
05:32

ASH 2021 Highlights on Ruxolitinib + Parsaclisib for JAK-/PI3K-Inhib…

ASH 2021 Conference Coverage on VuMedi

A. Yacoub

72 views
08:15

ASH 2021 Highlights in MPN

ASH 2021 Conference Coverage on VuMedi

P. Bose

254 views
15:25

ASH 2021 Clinical and Translational Data From the Ongoing MANIFEST T…

ASH 2021 Conference Coverage on VuMedi

M. Kremyanskaya

92 views
10:43

ASH 2021 Final Results of a Phase 2 Study of Sotatercept for Anemia …

ASH 2021 Conference Coverage on VuMedi

P. Bose

104 views
05:06

Positioning Fedratinib in the Treatment Strategy of Myelofibrosis

ASH 2021 Conference Coverage on VuMedi

F. Passamonti

144 views
13:17

ASH 2021 Molecular Responses in Treatment-Naïve HR-MDS Patients Trea…

ASH 2021 Conference Coverage on VuMedi

J. Garcia

80 views
12:03

ASH 2021 Highlights on Efficacy and Safety of Sabatolimab for Patien…

ASH 2021 Conference Coverage on VuMedi

A. Brunner

78 views
06:27

ASH 2021 Updates on the Phase 2 Study of Bomedemstat (IMG-7289) In P…

ASH 2021 Conference Coverage on VuMedi

H. Gill

483 views
07:56

ASH 2021 Rationale for and Results of a Phase I Study of the TGF-β 1…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

57 views
10:27

Splenomegaly in Polycythemia Vera: Clinical Significance and Relatio…

Richard T. Silver

337 views
10:44

A Real-World Evaluation of the Association Between Elevated Blood Co…

Aaron Gerds

1.1K views
15:40

ASH 2021 Update on the “AAA” Risk Model for Essential Thrombocythemi…

ASH 2021 Conference Coverage on VuMedi

A. Tefferi

442 views
05:15

ASH 2021 Update on Clinical Outcomes at 3 and 6 Months of Fedratinib…

ASH 2021 Conference Coverage on VuMedi

J. Mascarenhas

622 views